Insider Selling: BioCryst Pharmaceuticals (NASDAQ:BCRX) Insider Sells 50,906 Shares of Stock
BioCryst Pharmaceuticals insider Alane Barnes sold 50,906 shares at $7.21 each, totaling $367,032.26, reducing her stake by 12.23%. Post-sale, she holds 365,246 shares valued at $2,633,423.66. The sale was disclosed in an SEC filing. BioCryst's stock rose 9.6% to $7.85, with a trading volume of 7.6 million shares. Analysts have mixed ratings, with a consensus target price of $19.33. Institutional investors have adjusted their stakes in the company.